The long-awaited revised USP <797> guidelines will become official on November 1, 2023.
Evidence of the relationship between probiotics and antibiotics is lacking.
A discussion with Brittany Norton, PharmD, director of ambulatory care at Sutter Health.
The COVID-19 pandemic and social media have resulted in extreme levels of misinformation.
Relyvrio is intended to slow the disease progression of amyotrophic lateral sclerosis.
There may not be a diagnosis for ‘New Year Depression,’ but about 10% to 20% of individuals in the US may get a milder form of these winter blues.
Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.
Does anxiety justify an exemption from vaccine mandates among health care workers?
Evidence suggests some pharmaceutical excipients in medications may have adverse effects on pediatric patients. Here’s what you should know.
Efforts to improve education on biosimilars are a start, but payer policies must catch up to ensure real change.
On June 25, 2020, fenfluramine (Fintepla) was approved for the treatment of seizures associated with Dravet syndrome in patients 2 years and older.
During COVID-19, pharmacy technicians helped keep immunization programs running.
Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
From compounding to cleaning, oncology pharmacy technicians take on key responsibilities in infusion centers.
Jennifer Clements, PharmD, BCACP, BC-ADM, BCPS, CDCES, FADCES, FCCP, discussed current GLP-1 medication offerings and how each impacts patients differently.
The existing approach to disease management may be ill-suited to address the dynamic and diverse factors at play when it comes to chronic illness.
Jonathan Watanabe, PharmD, MS, PhD, BCGP, discussed gaps within primary care in the context of the American Society of Health-System Pharmacists 2025 Pharmacy Forecast.
GLP-1 receptor agonists, used to manage diabetes, are now being used for obesity in children and adolescents.
Kathryn Litten, PharmD, discussed the pharmacist’s role in helping patients manage metabolic dysfunction-associated steatotic liver disease.
A deep dive for pharmacists into this frequently debilitating disorder
Matthew Zirwas, MD, shares his step-by-step pearls for quelling the pruritic skin condition.
The drug’s approval was based on the results of 3 clinical trials.
Stimulant medications are the first-line pharmacologic therapy for ADHD, but many of these medications are currently in short supply.
Developing innovative solutions for women with depression, accounting for differences in gender and sex, are critically important
Researchers used an online English-language survey questionnaire to collect data on pharmacists from Germany and Switzerland about how their knowledge and dispensing frequency of biologics and biosimilars changed from before and after the pandemic.
Often referred to as “long COVID” patients or “long-haulers,” these patients continue to experience symptoms of illness far past the acute phase of this viral disease.
A perspective on the CMS Innovation Center roundtable on health equity.